DILI: Clinical Trials and Post-Marketing

This course is led by a Hepatologist with extensive experience in clinical assessment of DILI and who published ‘RUCAM’ the widely used causality assessment method of DILI.

参加申し込み

戻る Agenda

SESSION 1: THE LIVER: FUNCTIONAL ANATOMY AND PHYSIOLOGY CONCEPTS

Session Chair(s)

Gaby L. Danan, MD, PHD

Pharmacovigilance Expert

GLD, France

Fundamentals of liver functional anatomy and physiology needed to understand mechanisms for DILI

Speaker(s)

THE LIVER: FUNCTIONAL ANATOMY AND PHYSIOLOGY CONCEPTS

Gaby L. Danan, MD, PHD

GLD, France

Pharmacovigilance Expert

参加申し込み

DILI: Clinical Trials and Post-Marketing

SESSION 1: THE LIVER: FUNCTIONAL ANATOMY AND PHYSIOLOGY CONCEPTS

Session Chair(s)

Gaby L. Danan, MD, PHD

Speaker(s)

THE LIVER: FUNCTIONAL ANATOMY AND PHYSIOLOGY CONCEPTS

最新情報や機会を逃さないで